Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05483465 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of NAD Supplementation on Brain Vascular Health in Aging

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since May 9, 2024, no change to tracked fieldsv7-v8
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2023 to May 3, 2023
    • Site details revised
    v6
  3. Start date: Dec 1, 2022 to Apr 1, 2023
    • Primary completion date: Aug 2027 to Jun 2027
    • Study completion date: Aug 2027 to Dec 2027
    v5
  4. Start date: Sep 2022 to Dec 1, 2022v4
  5. Collaborators: 2 to 3v3
  6. Secondary endpoints: details revised at 8 of 15 entriesv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to test whether NR can also improve brain health and memory.
Trial Details
NCT Number NCT05483465
Lead Sponsor University of Oklahoma
Collaborators: University of Pennsylvania, Oklahoma Medical Research Foundation, Elysium Health
Conditions
(from sponsor)		 Aging
Enrollment 214 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov